The World Health Organisation (WHO) reports that 57 countries, one of which is New Zealand, collect 100% of their blood supply from voluntary, unpaid donors. Regular volunteers are considered the safest as the incidence of blood borne infections amongst these donors is minute. In support of World Blood Donor Day on June 14th, staff from […]
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has opened a new R&D facility within its Kawasaki Innovation Gateway at SKYFRONT in the city of Kawasaki, Kanagawa Prefecture, to pursue R&D in bioinformatics, a key technology toward the realisation of personalised medicine.
In order to continue supporting the initiatives of the GHIT Fund, which aims to assist in the application of Japanese technological innovation to healthcare in developing countries, we will be extending our provision of donations for a five-year period from 2018. By participating in the GHIT Fund, we will move forward with initiatives to develop and provide new reagents for infectious diseases in the aim of eradicating infectious diseases in developing countries.